EU drugs regulator studying expanded use of COVID-19 drug remdesivir
Reuters | Updated: 23-02-2021 15:12 IST | Created: 23-02-2021 14:44 IST
Europe's drugs regulator said on Tuesday it is evaluating the use of remdesivir in COVID-19 patients who do not need oxygen support after developer Gilead Sciences submitted an application to extend the medicine's use.
Europe had conditionally approved remdesivir, sold under the brand name Veklury, in July for treating COVID-19 in adults and adolescents with pneumonia requiring oxygen support.
Advertisement
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Europe
- Gilead Sciences
Advertisement